Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review
Jessie Luo, Nizar J. Bahlis, Denise Chan, Peter Duggan, Victor H. Jimenez-Zepeda, Holly Lee, Sylvia McCulloch, Paola Neri, Jason Tay · 2024
Read Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review by Jessie Luo, Nizar J. Bahlis, Denise Chan, Peter Duggan, Victor H. Jimenez-Zepeda, Holly Lee, Sylvia McCulloch, Paola Neri, Jason Tay (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11674242.txt.
Description
Jessie Luo and eight colleagues present a 2024 review of surprise cancers found on scans of blood cancer patients. PET and CT imaging used to stage a lymphoma or myeloma sometimes lights up a second, unrelated cancer. The team searched the medical literature for how often this happens and what follows.
Thirteen studies from 2008 to 2022 qualified. Important second cancers appeared in a median of about 2.4 percent of myeloma patients and 1.5 percent of patients with lymph cell cancers. The gut was the most common site, then the thyroid and lungs. Early discovery usually allowed successful early treatment. The authors urge quick, coordinated follow-up when scans reveal such findings, since they can change the whole treatment plan.
Catalog record
| CREATOR | Jessie Luo, Nizar J. Bahlis, Denise Chan, Peter Duggan, Victor H. Jimenez-Zepeda, Holly Lee, Sylvia McCulloch, Paola Neri, Jason Tay |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |